133 active trials 71 recruiting 3 Phase 3 31 disease areas 7 changes in 30 days
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
Primary endpoint(s) modified
Also in this update: Enrollment increased: 88 → 112 participants
Zhejiang UniversityNot applicable NCT07766668 Registry history of NCT07766668 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Zhejiang UniversityNot applicable NCT06859840 Registry history of NCT06859840 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from May 25, 2028 to Oct 15, 2028
Also in this update: Trial sites expanded: 4 → 7 locations; Completion pushed from May 25, 2029 to Oct 15, 2029
Zhejiang UniversityNot applicable NCT07596134 Registry history of NCT07596134 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Not Yet Recruiting
Zhejiang UniversityPhase 3 NCT06580288 Registry history of NCT06580288 on ClinicalTrials.gov (opens the registry)
Changed
| Early Phase 1 | 33 | |
| Phase 1 | 11 | |
| Phase 1/2 | 7 | |
| Phase 2 | 20 | |
| Phase 3 | 3 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07049094 | The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative… | Brain Tumor Adult | Recruiting | 2025-07-03 |
| Phase 3 | ||||
| NCT05593458 | Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For… | Locally Advanced Gastric Carcinoma | Recruiting | 2026-06-11 |
| NCT05813015 | Study of Comparing of With and Without Sequential Therapy of S-1 | Locally Advanced Gastric Adenocarcinoma | Recruiting | 2023-04-14 |
| NCT05699746 | CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD | Colorectal Cancer | Not Yet Recruiting | 2023-01-26 |
| Phase 2 | ||||
| NCT07789210 | A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus… | Colorectal Cancer | Recruiting | 2026-08-27 |
| NCT06770452 | HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced… | Metastatic Pancreatic Carcinoma | Recruiting | 2026-06-03 |
| NCT07581912 | Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally… | Colorectal Cancer | Recruiting | 2026-05-12 |
| NCT04661020 | CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma | Large B-Cell Lymphoma (LBCL) | Recruiting | 2026-04-07 |
| NCT05731726 | Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally… | pMMR | Recruiting | 2026-03-05 |
| NCT07240766 | HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation | Borderline Resectable Pancreatic Adenocarcinoma | Recruiting | 2026-02-13 |
| NCT07252336 | A Multicenter Study of CAR-T Cells in Primary Ph+All | ALL | Recruiting | 2025-12-04 |
| NCT07257653 | The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune… | Colorectal Neoplasms | Recruiting | 2025-12-02 |
| NCT06770439 | IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer | Advanced Pancreatic Cancers | Recruiting | 2025-09-23 |
| NCT07051980 | Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for… | Choledocholithiasis With Cholecystitis With Obstruction | Recruiting | 2025-07-17 |
| NCT07012772 | COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde… | Choledocholithiasis With Cholecystitis With Obstruction | Recruiting | 2025-06-24 |
| NCT05837052 | A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy… | Unresectable Lung Non-Small Cell Carcinoma | Recruiting | 2023-07-17 |
| NCT07779694 | 16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced… | pMMR/MSS | Not Yet Recruiting | 2026-09-08 |
| NCT07729917 | Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An… | Bile Duct Carcinoma | Not Yet Recruiting | 2026-07-28 |
| NCT07415525 | IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable… | Pancreatic Cancer | Not Yet Recruiting | 2026-02-17 |
| NCT07199855 | Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk… | B-Cell Acute Lymphoblastic Leukemia, Adult | Active, Not Recruiting | 2025-09-30 |
| NCT06962189 | The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for… | Non Small Cell Lung Cancer (Stage III) | Not Yet Recruiting | 2025-05-08 |
| NCT06848920 | Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced… | Differentiated Thyroid Carcinoma (DTC) | Not Yet Recruiting | 2025-02-27 |
| NCT06759090 | Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced… | Metastatic Pancreatic Carcinoma | Not Yet Recruiting | 2025-01-06 |
| NCT06172036 | Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab | Neoadjuvant Chemotherapy | Not Yet Recruiting | 2023-12-15 |
| Phase 1/2 | ||||
| NCT07123545 | Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | 2025-08-14 |
Leukemia (15) · Liver Cancer (14) · Pancreatic Cancer (14) · Acute Lymphoblastic Leukemia (ALL) (12) · Colorectal Cancer (11) · Gastric Cancer (9) · Non-Hodgkin Lymphoma (8) · Multiple Myeloma (6) · Acute Myeloid Leukemia (AML) (5) · Esophageal Cancer (5)